Finding 579916 (2022-004)

Material Weakness Repeat Finding
Requirement
C
Questioned Costs
-
Year
2022
Accepted
2023-12-05

AI Summary

  • Core Issue: The Director of Finance both initiated and authorized cash draws of federal funds, violating best practices for segregation of duties.
  • Impacted Requirements: This finding breaches 2 CFR 200.302(b)(4) and 2 CFR 200.303(a), which mandate effective control and accountability over federal funds.
  • Recommended Follow-up: Implement segregation of incompatible tasks to ensure that cash draws are authorized by someone other than the individual who initiates them.

Finding Text

Finding 2022-004: Material Weakness – Cash Management Cluster: Research and Development Cluster Assistance Listing: 93.084 Agency: Centers for Disease Control and Prevention Program: Prevention of Disease, Disability, and Death by Infectious Diseases Award Number: 1 U01CK000589-01-00, 6 U01CK000589-01-01, 6 U01CK000589-02-01, 5 U01CK000589- 02-00, 20U01CK00058920CV, 20U01CK00058921C3. Grant year: 2022 Assistance Listing: 47.070 Agency: National Science Foundation Program: Expeditions: Collaborative Research: Global Pervasive Computational Epidemiology. Award Number: 1918628 Grant year: 2021 Criteria: As required by 2 CFR 200.302(b)(4) of Financial Management, the non-federal entity must exercise effective control over, and accountability for, all federal funds. Per 2 CFR. 200.303(a), the non-federal entity should use the Internal Control Integrated Framework issued by the Committee of Sponsoring Organizations of the Treadway Commission (COSO) as a guideline. The COSO guideline indicates that proper segregation of duties between initiating and authorizing is a best practice as well as retaining documentation of performance and authorization controls. Condition: The Director of Finance both initiated and authorized cash draws of federal funds during the grant year. There was no supporting documentation of approval by an appropriate second party. 35 Cause: Lack of segregation of incompatible tasks. Effect: Lack of internal controls around supervising and authorizing cash management could result in mismanagement of federal funds. Context: Statistical sampling was not used, however, sampling in accordance with AICPA guidelines was applied. Questioned costs: There are no questioned costs associated with this finding. Repeat finding: This is a repeat finding. Recommendation: Initiating, authorizing, and recording should not be done by the same individual. Segregation of incompatible tasks should be implemented so that authorization and review of cash draws of federal funds is done by someone other than the individual who initiates and records the transaction. Management’s response (unaudited): Based on previous year’s finding, the management has implemented necessary remediation steps post the fiscal year-end. Accordingly, this finding remain unresolved as at the year-end

Categories

Internal Control / Segregation of Duties Cash Management Material Weakness Matching / Level of Effort / Earmarking

Other Findings in this Audit

  • 3471 2022-003
    Material Weakness Repeat
  • 3472 2022-004
    Material Weakness Repeat
  • 3473 2022-003
    Material Weakness Repeat
  • 3474 2022-004
    Material Weakness Repeat
  • 3475 2022-003
    Material Weakness Repeat
  • 3476 2022-004
    Material Weakness Repeat
  • 3477 2022-003
    Material Weakness Repeat
  • 3478 2022-004
    Material Weakness Repeat
  • 3479 2022-003
    Material Weakness Repeat
  • 3480 2022-004
    Material Weakness Repeat
  • 3481 2022-003
    Material Weakness Repeat
  • 3482 2022-004
    Material Weakness Repeat
  • 3483 2022-003
    Material Weakness Repeat
  • 3484 2022-004
    Material Weakness Repeat
  • 579913 2022-003
    Material Weakness Repeat
  • 579914 2022-004
    Material Weakness Repeat
  • 579915 2022-003
    Material Weakness Repeat
  • 579917 2022-003
    Material Weakness Repeat
  • 579918 2022-004
    Material Weakness Repeat
  • 579919 2022-003
    Material Weakness Repeat
  • 579920 2022-004
    Material Weakness Repeat
  • 579921 2022-003
    Material Weakness Repeat
  • 579922 2022-004
    Material Weakness Repeat
  • 579923 2022-003
    Material Weakness Repeat
  • 579924 2022-004
    Material Weakness Repeat
  • 579925 2022-003
    Material Weakness Repeat
  • 579926 2022-004
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
93.084 Prevention of Disease, Disability, and Death by Infectious Diseases $475,011
47.070 Computer and Information Science and Engineering $35,925